drug target identification
efficient drug discovery
Target Identification Screening Platform
human disorders
target identification methodologies
human neurodegenerative pathologies
human diseases
human populations
Neurodegenerative Disorders
betterment of human health
high-throughput compound screening system
high-throughput chemical compound screening
versatile platform
innovative platform
elegans
Nature
simple model organisms
context of NeuronAge
ever-increasing prevalence of devastating neurodegenerative conditions
defined nervous system
ERC project NeuronAge
malleable genetic model
marked decrease of neuronal function
linked facets of intervention strategies
state-of-the-art microfluidics technologies
European patent applications
Alzheimer’s
file US
pervasive societal impact
Parkinson’s disease
pre-demonstration stage
higher susceptibility
maladies
ataxias
manipulation of neurons
imaging
evolutionary conserved pathways
IPR protection
stroke
features
neurodegeneration
dependability
quality of life
attractive platforms
exploitation
Development of therapeutic interventions
Euro enterprise
innovation
course
experimental prowess of
potential commercialization opportunities
overarching aim
pressing priority
types of dementia
Ageing
Genes